期刊文献+

上皮样肉瘤的临床病理及免疫组织化学分析 被引量:4

Clinicopathologicobservation and Immunohistochemical Study of Epithelioid Sarcoma
下载PDF
导出
摘要 目的探讨上皮样肉瘤(ES)的临床病理学特征、诊断和鉴别诊断。方法收集13例ES,其中近端型9例,经典型4例。研究分析其临床资料、病理形态学及免疫组织化学分析结果,分析INI-1、CyclinD1二者表达的相关性。结果近端型以上皮样细胞为主,呈多结节状及弥漫片状生长方式;经典型兼具有梭形细胞及上皮样细胞,似肉芽肿样结构。免疫组织化学分析显示,肿瘤细胞Vimentin、CKpan、CD34、EMA、CyclinD1阳性,Desmin、S-100为弱阳性,CD31、CA125、HMB45、MelanA均为阴性。INI-l在经典型和近端型中的失表达率分别为77.8%(7/9)和75.0%(3/4),二者比较差别无统计学意义(P>0.05)。INI-1与CyclinD1蛋白表达无明显相关性(P>0.05)。结论 ES少见,易误诊,结合病史,联合应用INI-1、Vimentin、CKpan、EMA、CD34等指标对ES的诊断及鉴别诊断有帮助;在ES中存在INI-1失表达与CyclinD1过表达现象,但二者无明显相关性。 Objective To explore the clinicopathologic features,diagnosis and differential diagnosis of epithelioid sarcoma(ES). Methods The clinical data,histopathologic observation and immunohistochemical staining were studied in 13 cases of ES. Correlation of INI-l and CyclinD1 protein expression was analyzed. Results Among the 13 cases of ES,4were conventional ES and 9were of proximal-type ES. Proximal-type ES consisted of epithelioid cells,which showed an infiltrative growth pattern with nodular and sheet arrangement. Conventional ES consisted of epithelioid cells and spindle cells,with a granuloma-like pattern. The immunohistochemical study showed expression of Vimentin,CKpan,CD34,EMA,CyclinD1. The immunostain for Desmin,S100,which was focal and weak was found.CD31,CA125,HMB45 and MelanA were negative in all cases. The loss of INI-1was found in 77.8%(7/9)and 75.0%(3/4)in the conventional ES and the proximal-type ES,respectively. There were no significant differences in negative rate of INI-1protein between the conventional ES and the proximal-type ES(P〉0.05). The loss expression of INI-1protein is not associated with the high expression of CyclinD1protein(P〉0.05). Conclusions Owing to low incidence,pitfalls in diagnosis of ES sometimes are encountered. Immunostaining for INI-1combined with other commonly used markers(Vimentin,CKpan,EMA and CD34)will be helpful for correct diagnosis. Upregulation of CyclinD1 expression and loss of INI-1expression was found in ES and there is not association between the two.
出处 《福建医科大学学报》 北大核心 2016年第2期98-102,共5页 Journal of Fujian Medical University
关键词 肉瘤 诊断 免疫组织化学 肿瘤/病理学 抗体 sarcoma diagnosis immunohistochemistry neoplasms/pathology antibodies
  • 相关文献

参考文献13

  • 1Enzinger F M. Epitheloid sarcoma. A sarcoma simulating a granu- loma or a carcinoma[J]. Cancer, 1970,26(5):1029-1041.
  • 2Oda Y, Dal Cin P, Laskin W B. Epithelioid sarcoma[M]// Fletcher C D, Unni K K, Mertens F. WHO classification of tumours of soft tissue and bone. Lyon= IARC Press, z01a= 216-218.
  • 3王坚,朱雄增.软组织肿瘤痛理学[M].北京:人民卫生出版社,2008:529-535.
  • 4Izumi T, Oda Y, Hasegawa T, et al. Prognostic significance of dysadherin expression in epithelioid sarcoma and its diagnos- tic utility in distinguishing epithelioid sarcoma from malignant rhabdoid tumor[J]. Mod Pathol, 2006,19(6) :820-831.
  • 5李莉,夏秋媛,饶秋,刘标,吴波,时姗姗,余波,章如松,陆珍凤,周晓军.上皮样肉瘤免疫表型和INI1基因改变的研究[J].中华病理学杂志,2014,43(6):389-393. 被引量:14
  • 6Modena P, Lualdi E, Facchinetti F, et al. SMARCB1/INI-1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas[J]. Cancer Res, 2005,65 (10) : 4012-4019.
  • 7Imbalzano A N, ]ones S N. Snf5 tumor suppressor couples chromatin remodeling, checkpoint control, and chromosomal stability[J]. Cancer Cell, 2005,7(4) :294-295.
  • 8Brenca M, Rossi S, Lorenzetto E, et al. SMARCB1/INI-1 ge- netic inactivation is responsible or tunlorigenic properties of epithelioid sarcoma cellline VAESBJ [J]. Mol Cancer Ther, 2013,12 (6) : 1060-1072.
  • 9Noujaim J, Thway K, Bajwa Z, et al. Epithelioid sarcoma: opportunities for biology-driven targeted therapy [J]. Front Oncol, 2015,17(5):186.
  • 10Arnold M A, Arnold C A, Li G, et al. A unique pattern of INI-1 immunohistoehemistry distinguishes synovial sarcoma from its histologic mimics[J]. Hum Pathol, 2013,44 (5) : 881-887.

二级参考文献15

  • 1Ross HM, Lewis JJ, Woodruff JM, et al. Epithelioid sarcoma: clinical behavior and prognostic factors of survival[ J ]. Ann Surg Oncol, 1997,4(6) :491-495.
  • 2Sullivan LM, Folpe AL, Pawel BR, et al. Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions [ J ]. Mod Pathol, 2013,26(3) :385-392.
  • 3Gasparini P, Facchinetti F, Boeri M, et al. Prognostic determinants in epithelioid sarcoma[ J]. Ear J Cancer, 2011,47 (2) :287-295.
  • 4Oda Y, Dal Cin P, Laskin WB. Epithelioid sarcoma [ M ]// Fletcher CD, Unni KK, Mertens F. WHO classification of tumours of soft tissue and bone. Lyon: IARC Press, 2013:216-218.
  • 5Dagar V, Chow CW, Ashley DM, et al. Rapid detection of SMARCB1 sequence variation using high resolution melting[ J]. BMC Cancer, 2009,9:437.
  • 6Rao Q, Liu B, Cheng L, et al. Renal cell carcinomas with t(6; 11 ) ( p21 ; q12 ) : a clinicopathologic study emphasizing unusual morphology, novel alpha-TFEB gene fusion point, immunobiomarkers, and ultrastructural features, as well as detection of the gene fusion by fluorescence in situ hybridization [J]. Am J Surg Pathol, 2012,36(9) :1327-1338.
  • 7Enzinger FM. Epitheloid sarcoma. A sarcoma simulating a granuloma or a carcinoma[ Jl. Cancer, 1970,26(5 ) : 1029-1041.
  • 8Guillou L, Wadden C, Coindre JM, et al. " Proximal-type" epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series[ J]. Am J Surg Pathol, 1997,21 (2) :130-146.
  • 9Versteege I, Sévenet N, Lange J, et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer[ J]. Nature, 1998, 394 ( 6689 ) :203-206.
  • 10Amary MF, O' Donnell P, Berisha F, et al. Pseudomyogenic ( epithelioid sarcoma-like) hemangioendothelioma: characterization of five cases[J]. Skeletal Radiol, 2013,42(7) :947-957.

共引文献13

同被引文献13

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部